Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) focusing on viral vector manufacturing, has entered into a strategic development partnership with CytoImmune, a biotechnology company based in Puerto Rico. This collaboration aims to advance a clinical
BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), has announced a partnership with Centivax, Inc. The collaboration aims to develop Centivax’s universal influenza vaccine, Cent-Flu, which utilises a proprietary mixture of 22 unique mRNA transcripts
Andelyn Biosciences, Inc., a contract development and manufacturing organisation (CDMO) specialising in cell and gene therapies, has been selected by Hubble Therapeutics to manufacture adeno-associated virus (AAV) for the treatment of Leber Congenital Amaurosis 16 (LCA16), a rare and severe
Mestag Therapeutics has announced a new collaboration and licensing agreement with MSD (Merck & Co., Inc., Rahway, N.J., USA) to develop novel therapies aimed at treating inflammatory diseases. This agreement will leverage Mestag’s proprietary Reversing Activated Fibroblast Technology (RAFT) platform
OneSource Specialty Pharma, a newly established CDMO, was officially launched at CPHI Milan following the merger of three CDMO businesses within the Strides Group. The company specialises in biologics, drug-device combinations, and soft gelatin capsules, supported by over 30 years
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has opened a €290 million biosafety testing facility in Rockville, Maryland. The new 23,000-square-meter facility is designed to meet growing global demand for biosafety testing and analytical
Pharmaceutics International Inc. (Pii) has launched the Accelevate Early Development Platform, aiming to help small and mid-sized pharmaceutical companies accelerate their path to Investigational New Drug (IND) readiness in just 100 days. This platform targets aseptic products and supports companies
ReiThera, in collaboration with the Sabin Vaccine Institute, has commenced a pivotal role in addressing the Marburg virus outbreak by manufacturing and shipping around 700 investigational vaccine doses to Rwanda. This shipment supports a Phase 2 rapid response clinical trial
Wheeler Bio has announced the appointment of Patrick Lucy as its new Chief Executive Officer, signalling a key leadership shift as the company moves towards expanding its contract development and manufacturing (CDMO) capabilities. With more than 32 years of experience
Cellipont Bioservices has entered into an agreement with biopharmaceutical company Mongoose Bio to support the technology transfer, process development, and clinical-grade manufacturing of Mongoose’s autologous TCR-T cell therapy, MGB-001. The partnership will focus on delivering this advanced therapy, designed to
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
